ESTA moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 47 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ESTA's RSI Oscillator exited the oversold zone, 20 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ESTA as a result. In 79 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ESTA just turned positive on October 20, 2026. Looking at past instances where ESTA's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.
Following a +6.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESTA advanced for three days, in 240 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for ESTA moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
ESTA broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ESTA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ESTA's P/B Ratio (92.439) is very high in comparison to the industry average of (4.142). P/E Ratio (-52.772) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.749) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. ESTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RDNT's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator showed a similar pattern. In 181 of the 210 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RDNT as a result. In 64 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.
RDNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RDNT crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 230 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The 10-day RSI Indicator for RDNT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 29 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
RDNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.457) is normal, around the industry mean (67.298). RDNT's P/E Ratio (-292.308) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ESTA | RDNT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 12 Undervalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 37 | |
SMR RATING 1..100 | 99 | 91 | |
PRICE GROWTH RATING 1..100 | 54 | 42 | |
P/E GROWTH RATING 1..100 | 15 | 77 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDNT's Valuation (1) in the Medical Or Nursing Services industry is in the same range as ESTA (12) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to ESTA’s over the last 12 months.
RDNT's Profit vs Risk Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for ESTA (100) in the Medical Specialties industry. This means that RDNT’s stock grew somewhat faster than ESTA’s over the last 12 months.
RDNT's SMR Rating (91) in the Medical Or Nursing Services industry is in the same range as ESTA (99) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to ESTA’s over the last 12 months.
RDNT's Price Growth Rating (42) in the Medical Or Nursing Services industry is in the same range as ESTA (54) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to ESTA’s over the last 12 months.
ESTA's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for RDNT (77) in the Medical Or Nursing Services industry. This means that ESTA’s stock grew somewhat faster than RDNT’s over the last 12 months.
| ESTA | RDNT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 77% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 80% |
| Advances ODDS (%) | 4 days ago 78% | 9 days ago 74% |
| Declines ODDS (%) | 11 days ago 77% | 7 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESTA’s FA Score shows that 2 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESTA’s TA Score shows that 5 TA indicator(s) are bullish while RDNT’s TA Score has 6 bullish TA indicator(s).
ESTA (@Medical/Nursing Services) experienced а +5.60% price change this week, while RDNT (@Medical Specialties) price change was -2.72% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.83%. For the same industry, the average monthly price growth was -5.05%, and the average quarterly price growth was +38.36%.
ESTA is expected to report earnings on Mar 02, 2027.
RDNT is expected to report earnings on Mar 02, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-4.83% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, ESTA has been loosely correlated with NPCE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ESTA jumps, then NPCE could also see price increases.
| Ticker / NAME | Correlation To ESTA | 1D Price Change % | ||
|---|---|---|---|---|
| ESTA | 100% | +5.15% | ||
| NPCE - ESTA | 48% Loosely correlated | -1.34% | ||
| RDNT - ESTA | 41% Loosely correlated | +0.18% | ||
| NVST - ESTA | 39% Loosely correlated | -2.01% | ||
| LIVN - ESTA | 37% Loosely correlated | -0.18% | ||
| NTRA - ESTA | 37% Loosely correlated | +2.51% | ||
More | ||||
A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To RDNT | 1D Price Change % | ||
|---|---|---|---|---|
| RDNT | 100% | +0.18% | ||
| ITGR - RDNT | 49% Loosely correlated | +0.05% | ||
| GKOS - RDNT | 48% Loosely correlated | +4.64% | ||
| NNOX - RDNT | 46% Loosely correlated | -2.52% | ||
| ICUI - RDNT | 43% Loosely correlated | -2.11% | ||
| CERS - RDNT | 42% Loosely correlated | +8.72% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LABU | 241.75 | 5.43 | +2.30% |
| Direxion Daily S&P Biotech Bull 3X ETF (LABU) | |||
| AIYY | 7.29 | 0.14 | +1.96% |
| YieldMax AI Option Income Strategy ETF (AIYY) | |||
| UFEB | 39.75 | 0.26 | +0.66% |
| Innovator U.S. Equity Ultra Buffer ETF - February (UFEB) | |||
| QLTY | 44.47 | 0.21 | +0.47% |
| GMO US Quality ETF (QLTY) | |||
| SIMS | 45.22 | -0.48 | -1.06% |
| State Street SPDR S&P Kensho Intelligent Structures ETF (SIMS) | |||